These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25213362)

  • 1. Anti-CD20 antibody in primary Sjögren's syndrome management.
    Chen S; Liu Y; Shi G
    Curr Pharm Biotechnol; 2014; 15(6):535-41. PubMed ID: 25213362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell populations and sub-populations in Sjögren's syndrome.
    Hamza N; Bos NA; Kallenberg CG
    Presse Med; 2012 Sep; 41(9 Pt 2):e475-83. PubMed ID: 22841377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy.
    Hamza N; Bootsma H; Yuvaraj S; Spijkervet FK; Haacke EA; Pollard RP; Visser A; Vissink A; Kallenberg CG; Kroese FG; Bos NA
    Ann Rheum Dis; 2012 Nov; 71(11):1881-7. PubMed ID: 22615459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?
    Meiners PM; Vissink A; Kallenberg CG; Kroese FG; Bootsma H
    Expert Opin Biol Ther; 2011 Oct; 11(10):1381-94. PubMed ID: 21819314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.
    Carubbi F; Cipriani P; Marrelli A; Benedetto P; Ruscitti P; Berardicurti O; Pantano I; Liakouli V; Alvaro S; Alunno A; Manzo A; Ciccia F; Gerli R; Triolo G; Giacomelli R
    Arthritis Res Ther; 2013 Oct; 15(5):R172. PubMed ID: 24286296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab in primary Sjögren's syndrome: a ten-year journey.
    Carubbi F; Alunno A; Cipriani P; Bartoloni E; Ciccia F; Triolo G; Gerli R; Giacomelli R
    Lupus; 2014 Nov; 23(13):1337-49. PubMed ID: 25096066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic treatments in Sjögren's syndrome.
    Bowman S; Barone F
    Presse Med; 2012 Sep; 41(9 Pt 2):e495-509. PubMed ID: 22836195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study.
    Alunno A; Carubbi F; Bistoni O; Caterbi S; Bartoloni E; Di Benedetto P; Cipriani P; Giacomelli R; Gerli R
    Clin Exp Immunol; 2016 Jun; 184(3):284-92. PubMed ID: 26814615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKp30 Receptor Upregulation in Salivary Glands of Sjögren's Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment.
    Pontarini E; Sciacca E; Grigoriadou S; Rivellese F; Lucchesi D; Fossati-Jimack L; Coleby R; Chowdhury F; Calcaterra F; Tappuni A; Lewis MJ; Fabris M; Quartuccio L; Bella SD; Bowman S; Pitzalis C; Mavilio D; De Vita S; Bombardieri M
    Front Immunol; 2021; 12():706737. PubMed ID: 34594326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [First experience with the application of rituximab for the treatment of patients with Sjogren's syndrome and disease].
    Vasil'ev VI; Logvinenko OA; Kokosadze NV; Gaĭduk IV; Varlamova EIu; Kovrigina AM; Gorodetskiĭ VR; Nasonov EL
    Vestn Ross Akad Med Nauk; 2009; (2):3-10. PubMed ID: 19283903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [B-cell depletion and primary Sjögren's syndrome: is there a role for rituximab?].
    Atzeni F; Sarzi-Puttini P
    Reumatismo; 2010; 62(2):87-8. PubMed ID: 20657883
    [No Abstract]   [Full Text] [Related]  

  • 12. The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome.
    Saraux A
    Autoimmun Rev; 2010 Jul; 9(9):609-14. PubMed ID: 20452466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's Syndrome.
    Brown S; Navarro Coy N; Pitzalis C; Emery P; Pavitt S; Gray J; Hulme C; Hall F; Busch R; Smith P; Dawson L; Bombardieri M; Wan-Fai N; Pease C; Price E; Sutcliffe N; Woods C; Ruddock S; Everett C; Reynolds C; Skinner E; Poveda-Gallego A; Rout J; Macleod I; Rauz S; Bowman S;
    BMC Musculoskelet Disord; 2014 Jan; 15():21. PubMed ID: 24438039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab therapy in primary Sjögren's syndrome.
    Alcântara C; Gomes MJ; Ferreira C
    Ann N Y Acad Sci; 2009 Sep; 1173():701-5. PubMed ID: 19758218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.
    Cornec D; Costa S; Devauchelle-Pensec V; Jousse-Joulin S; Marcorelles P; Berthelot JM; Chiche L; Hachulla E; Hatron PY; Goeb V; Vittecoq O; Saraux A; Pers JO
    J Autoimmun; 2016 Feb; 67():102-110. PubMed ID: 26688003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell depletion and repopulation in autoimmune diseases.
    Pers JO; Daridon C; Bendaoud B; Devauchelle V; Berthou C; Saraux A; Youinou P
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):50-5. PubMed ID: 18270858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD20 treatment in primary Sjögren's syndrome.
    Isaksen K; Jonsson R; Omdal R
    Scand J Immunol; 2008 Dec; 68(6):554-64. PubMed ID: 19000095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab therapy for primary Sjögren's syndrome: an open-label clinical trial and mechanistic analysis.
    St Clair EW; Levesque MC; Prak ET; Vivino FB; Alappatt CJ; Spychala ME; Wedgwood J; McNamara J; Moser Sivils KL; Fisher L; Cohen P;
    Arthritis Rheum; 2013 Apr; 65(4):1097-106. PubMed ID: 23334994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Sjogren's syndrome: current and prospective therapies.
    Thanou-Stavraki A; James JA
    Semin Arthritis Rheum; 2008 Apr; 37(5):273-92. PubMed ID: 17714766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune regulation and B-cell depletion therapy in patients with primary Sjögren's syndrome.
    Abdulahad WH; Kroese FG; Vissink A; Bootsma H
    J Autoimmun; 2012 Aug; 39(1-2):103-11. PubMed ID: 22341852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.